3. Administrative Core Dr. Samuel E. Adunyah and Dr. Steven Wolff, in conjuncfion with the other Partnership Co-Principal Invesfigators, will be responsible for the overall conduct of Partnership acfivities as well as the decision-making processes. These include: 1) oversight of the Partnership's objecfives to strengthen and expand competitive cancer research capabilifies 2) create stable, long-term collaborafive relationships between MMC, TSU and the VICC in cancer research, outreach, training and career development 3) promote a stable, long-term partnership based on mutually beneficial research excellence 4) overall planning, coordination and implementafion of internal and external evaluation activities 5) facilitafion of inter-insfitutional initiafives in cancer research 6) budgetary decisions. The MMC component of the Partnership will be administered and managed through well-established infrastructure under the leadership of the Lead Principal Invesfigator, Dr. Samuel E. Adunyah and Co-Principal Investigator, Dr. Steven Wolff. The administrative core is responsible for providing the support necessary to achieve and maintain the highest standards of excellence in cancer research at MMC. Since inception of the cancer partnership MMC has strengthened its cancer research infrastructure. This expansion of cancer research capability in MMC has gained the support of Departmental Chairs and Deans of the Schools of Medicine and Graduate Studies and Research to which some Partnership invesfigators will be reporting. As part if the overall partnership administrative core, our Administrative Core Leadership will play a key role in determining the overall direction for cancer research activities and cancer research training which meet goals and objectives ofthis Partnership. .

National Institute of Health (NIH)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Meharry Medical College
United States
Zip Code
Brown, Shyretha; Whalen, Margaret (2015) Tributyltin alters secretion of interleukin 1 beta from human immune cells. J Appl Toxicol 35:895-908
Vaiopoulou, Anna; Gazouli, Maria; Papadopoulou, Aggeliki et al. (2015) Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr 60:42-7
Sanderson, Maureen; O'Hara, Heather; Foderingham, Nia et al. (2015) Type 2 diabetes and mammographic breast density among underserved women. Cancer Causes Control 26:303-9
Khabele, Dineo; Kabir, Syeda M; Dong, Yuanlin et al. (2014) Preferential effect of akt2-dependent signaling on the cellular viability of ovarian cancer cells in response to EGF. J Cancer 5:670-8
Myers, Jeremy N; Schäffer, Michael W; Korolkova, Olga Y et al. (2014) Implications of the colonic deposition of free hemoglobin-? chain: a previously unknown tissue by-product in inflammatory bowel disease. Inflamm Bowel Dis 20:1530-47
Li, Bo; Lu, Wenfu; Chen, Zhenbang (2014) Regulation of Androgen Receptor by E3 Ubiquitin Ligases: for More or Less. Receptors Clin Investig 1:
Nangami, Gladys; Koumangoye, Rainelli; Shawn Goodwin, J et al. (2014) Fetuin-A associates with histones intracellularly and shuttles them to exosomes to promote focal adhesion assembly resulting in rapid adhesion and spreading in breast carcinoma cells. Exp Cell Res 328:388-400
Patel, Kushal; Kanu, Mohamed; Liu, Jianguo et al. (2014) Factors influencing breast cancer screening in low-income African Americans in Tennessee. J Community Health 39:943-50
Rekhadevi, P V; Diggs, D L; Huderson, A C et al. (2014) Metabolism of the environmental toxicant benzo(a)pyrene by subcellular fractions of human ovary. Hum Exp Toxicol 33:196-202
Li, Bo; Lu, Wenfu; Yang, Qing et al. (2014) Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer. Prostate 74:421-32

Showing the most recent 10 out of 18 publications